The Caliciviruses Section addresses the role of human caliciviruses in human disease, with a focus on the development of prevention and control strategies for the noroviruses.
Kim Green, Ph.D.
Chief, Caliciviruses Section
Ph.D., The University of Tennessee Health Science Center (UTHSC), Memphis, Tennessee
Natthawan Chaimongkol, Ph.D. (She/Her/Hers)
Ph.D., Graduate School of Medicine, 2013, Tohoku University, Japan
Languages Spoken: Thai
Yuki Matsushima, Ph.D. (He/Him/His)
Ph.D., School of Medicine, 2017, Yokohama City University, Japan
Languages Spoken: Japanese
Former Research Group Members
Former Postdoctoral Trainees:
2000-2005, Gaël Belliot
Centre Hospitalier Universitaire, Dijon FR
2002-2005, Kyeong-OK Chang
Kansas State University School of Veterinary Medicine
2006-2013, Karin Bok, Ph.D.
Acting Deputy Director
Pandemic Preparedness and Emergency Response
VRC, NIAID, National Institutes of Health
2009-2016, Gabriel I. Parra, Ph.D.
Office of Vaccines Research and Review
2014-2017, Dennise De Jesus Diaz, Ph.D.
Chief Operations Officer
Remedy Plan Therapeutics
2014-2019, Eric Levenson, Ph.D.
Staff Fellow CBER/FDA